小剂量γ线照射及合并噪声暴露对豚鼠外周血NK细胞活性的影响

实验研究了小剂量γ线照射及合并噪声暴露对脉鼠外周血ＮＫ细胞活性的影响。结果表明，单纯γ线照射和单纯噪声暴露组动物外周血ＮＫ细胞活性较对照组部有一定程度的增高，其中尤以后者为明显。但噪声暴露对γ线照射引起的ＮＫ细胞活性无明显影响；而γ线照射对噪声暴露引起的ＮＫ细胞活性却表现有一定的拮抗作用，其机理有待探讨。     

Correlation between Cyclin A Gene Expression in Adult Patients with Acute Leukemia and Drug Resistance

Adultacuteleukemia (AL)isoneofthemostcommonmalignanttumorsofhematology .Withtherecentprogressinchemotherapyandsupportivether apy ,theremissionandsurvivalrateinALhavebeenmarkedlyimproved .However ,drugresistanceandrelapsearestillimportantfactorsaffectinglongsur vivalofthese patients .Theabnormalregulationofcellcycleisanotherfactorthatcannotbeignoredex ceptformultipledrugresistance (MDR) .WedetectcyclinA ,multidrugresistantgene (mdrl) ,topoiso meraseⅡα(TopⅡα)andbcl 2inadultpatientswithA…     

基于DSP的远程监护终端系统的研究

阐述一种基于DSP的远程家庭监护终端的程序设计。包括心电的采集，用小波变换完成QRS波的检测，最后将心电波形数据和检测结果通过互联网传输到医院的心电服务器上。     

光动力学疗法与局部化疗联合治疗进展期食管贲门癌

作应用光动力学疗法（ＰＤＴ）对进展期食管贲门癌５５例进行治疗，并对其中１５例联合应用内镜下局部注射抗癌药物。对每一患均先静脉滴注血卟啉衍生物（ＨＰＤ）５ｍｇ／ｋｇ，于用药后２４，４８和７２ｈ分别用波长６３０ｎｍ的铜蒸汽激光照射肿瘤部位。联合治疗组除ＰＤＴ治疗外，于每次光照前肿瘤局部注射５－Ｆｕ２５０～５００ｍｇ。结果：联合治疗组的近期显效率高于单纯ＰＤＴ组（Ｐ〈０．０５）。病例随访６～１６月，     

从早产儿脐带血中分离出流行性出血热病毒的探讨

１９９２年１２月作者从一位ＥＨＦ患者的早产儿脐带血中分离出ＥＨＦＶ，证实ＥＨＦＶ沿母、婴垂直途径传播的可能性。     

A primary gastric Burkitt's lymphoma in a child]

We report a case of a primary gastric Burkitt's lymphoma in a 8-year-old child, which first symptoms were abdominal pain, dysphagia, melena and a constitutional syndrome. The differential characteristics of this case are its peculiar gastric infiltration and the existence of oesophageal extension, which is very infrequent among this kind of tumors.     

辽宁产东亚钳蝎毒镇痛作用与脑内中枢关系的研究

应用立体定位、核团内注射与电解损毁核团技术及微电极细胞外记录方法，以猫丘脑后核内脏大神经诱发单位放电为内脏痛指标，观察向尾状核、中脑导水管周围灰质及杏仁内侧核内注入东亚钳蝎毒及在电解损毁３个核团前后ＰＯ内脏大神经诱发单位放电的变化。在损毁诸核之前刺激内脏大神经引起单位诱发放电，损毁诸核之后诱发放电减弱或消失，这与辽宁产东亚钳蝎毒注入诸核团中的作用相一致。表明蝎毒的作用部位与上述核团有关，更进一步证明蝎毒作用部位     

广东汉族人群HLA-Cw多态性及单体型分析

目的检测广东汉族人群HLA．Cw及HLA-A、B、DRB1基因频率，分析该人群HLA-Cw等位基因多态性及其单体型特点。方法骨髓移植供者185例，抗凝血提取DNA，半量全自动PCR-RSSO分型检测HLA-A、B、Cw、DRB1基因型。结果在分辨水平检出Cw等位基因11个，其中分布频率较高的依次为：Cw*03(0．2580)、Cw*07(0．1887)、Cw*01(0．1732)、Cw*08(0．1070)。统计分析呈现显著连锁不平衡的HLA-Cw．A单体型7个，HLA-Cw-B单体型20个，HLA—Cw．DRB1单体型10个。结论广东汉族群体HLA-Cw基因具有较为丰富的多态性，其与HLA-A、B、DRB1间连锁不平衡单体型具有地区性遗传特征。     

系统性红斑狼疮患者血清中4种胶原成分变化的临床意义

目的：探讨活动性系统性红斑狼疮(SLE)患者血清中4种胶原成分的变化及临床意义。方法：采用放射免疫分析法对41例活动期SLE患者及其中伴有沸间质改变、肾脏改变、雷诺征或三者共存者血清Ⅲ型前胶原(PC—Ⅲ)、Ⅳ型肢原(Ⅳ—C)、透明质酸(HA)、层粘连蛋白(LN)进行到定。结果：4种胶原成分均明显高于对照组(P＜0．01或P＜0.05)。结论：4种胶原成分的变化在SLE的诊断、治疗、病情判定、评估预后中，特别是肝、肾、肺病变的监测中具有重要作用。     

Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.

Transiliac bone biopsies were obtained from 55 women treated with teriparatide or placebo for 12-24 months. We report direct evidence that modeling bone formation at quiescent surfaces was present only in teriparatide-treated patients and bone formation at remodeling sites was higher with teriparatide than placebo. INTRODUCTION: Recombinant teriparatide [human PTH(1-34)], a bone formation agent for the treatment of osteoporosis when given once daily subcutaneously, increases biochemical markers of bone turnover and activation frequency in histomorphometry studies. MATERIALS AND METHODS: We studied the mechanisms underlying this bone-forming action of teriparatide at the basic multicellular unit by the appearance of cement lines, a method used to directly classify surfaces as modeling or remodeling osteons, and by the immunolocalization of IGF-I and IGF-II. Transiliac bone biopsies were obtained from 55 postmenopausal women treated with teriparatide 20 or 40 microg or placebo for 12-24 months (median, 19.8 months) in the Fracture Prevention Trial. RESULTS: A dose-dependent relationship was observed in modeling and mixed remodeling/modeling trabecular hemiosteons. Trabecular and endosteal hemiosteon mean wall thicknesses were significantly higher in both teriparatide groups than in placebo. There was a dose-dependent relationship in IGF-II immunoreactive staining at all bone envelopes studied. The greater local IGF-II presence after treatment with teriparatide may play a key role in stimulating bone formation. CONCLUSIONS: Direct evidence is presented that 12-24 months of teriparatide treatment induced modeling bone formation at quiescent surfaces and resulted in greater bone formation at remodeling sites, relative to placebo.